IDEXX Laboratories, Inc. (IDXX)
NasdaqGS • Currently up 7.85 (+1.45%) in today's trading session
3 members of Congress have disclosed 18 trades in IDEXX Laboratories, Inc. (IDXX) via STOCK Act filings. The most recent disclosure was a sale by April McClain Delaney on 13 January 2026. The most active traders have been April McClain Delaney (9), Gilbert Cisneros (7), and Byron Donalds (2). Aggregate disclosed activity totals roughly $80K in purchases and $64K in sales (midpoint estimates from bracketed disclosure amounts).
IDEXX Laboratories, Inc. is currently trading at $549.16, positioned at 16% of its 52-week range ($506.91 – $769.98).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Not available in the US.
Past Performance is not an indication of future results.
*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.
IDEXX Laboratories, Inc. Price History and Technical Analysis
Congressional Trading Activity for IDXX
| April McClain Delaney | 13 Jan 2026 | 2 Feb 2026 | Sale | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 2 Dec 2025 | 5 Jan 2026 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Byron Donalds | 4 Sept 2025 | 7 Oct 2025 | Purchase | Stock | $1,001 - $15,000 | -13.37% | |
| Byron Donalds | 4 Sept 2025 | 7 Oct 2025 | Purchase | Stock | $1,001 - $15,000 | -13.37% | |
| April McClain Delaney | 7 Aug 2025 | 2 Sept 2025 | Sale | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 1 Aug 2025 | 2 Sept 2025 | Sale | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 9 Apr 2025 | 2 May 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 7 Apr 2025 | 2 May 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 4 Apr 2025 | 2 May 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 1 Apr 2025 | 2 May 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| April McClain Delaney | 14 Mar 2025 | 2 Apr 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 9 Oct 2020 | 5 Nov 2020 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 11 Aug 2020 | 14 Sept 2020 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 10 Jun 2020 | 17 Jul 2020 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 9 Apr 2020 | 13 May 2020 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 3 Jun 2019 | 18 Jun 2019 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 27 Feb 2019 | 8 Mar 2019 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 26 Feb 2019 | 8 Mar 2019 | Purchase | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
MCK
McKesson Corporation
LLY
Eli Lilly and Company
MRK
Merck & Co., Inc.
Frequently Asked Questions about IDXX
- Which members of Congress have traded IDXX?
- 3 members of Congress have disclosed 18 trades in IDEXX Laboratories, Inc. (IDXX) under the STOCK Act. The most active traders are April McClain Delaney, Gilbert Cisneros, and Byron Donalds.
- When was IDXX most recently disclosed by Congress?
- The most recent IDXX disclosure was a sale by April McClain Delaney on 13 January 2026.
- What is the total disclosed congressional trading volume for IDXX?
- Members of Congress have disclosed approximately $80K in IDXX purchases and $64K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
- How can I track new congressional trades in IDXX?
- This IDXX page updates as soon as new STOCK Act disclosures are filed for IDEXX Laboratories, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track IDXX in Congress
See when politicians buy or sell this stock